Literature DB >> 5064171

Synergism of antibiotic combinations against treponemes.

I J Abramson, R M Smibert.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5064171      PMCID: PMC1048284          DOI: 10.1136/sti.48.2.113

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


× No keyword cloud information.
  7 in total

1.  A WHO study of treatment schedules for early syphilis in use throughout the world.

Authors:  R R WILLCOX
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

2.  Antibiotic combinations and resistance to antibiotics; penicillin-erythromycin and streptomycin-erythromycin combinations in vitro.

Authors:  E M PURCELL; S S WRIGHT; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1953-01

3.  Effect of different media on in vitro studies of antibiotic combinations.

Authors:  R J Bulger; K Nielson
Journal:  Appl Microbiol       Date:  1968-06

4.  Inhibition of growth of treponemes by antimicrobial agents.

Authors:  I J Abramson; R M Smibert
Journal:  Br J Vener Dis       Date:  1971-12

5.  Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents.

Authors:  T C Eickhoff; J V Bennett; P S Hayes; J Feeley
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

6.  Factors which influence synergism by neomycin and oxytetracycline.

Authors:  B J Williams
Journal:  Appl Microbiol       Date:  1971-04

7.  New approach for the evaluation of antimycobacterial drug combinations in vitro (the laboratory model man).

Authors:  K D Stottmeier; C L Woodley; G P Kubica
Journal:  Appl Microbiol       Date:  1969-09
  7 in total
  2 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain).

Authors:  S J Norris; D G Edmondson
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.